poisar

Stocks · News reference

Chardan Initiates Coverage of Vicore Pharma Holding with Buy Rating

Fiscal.ai

Investment firm Chardan has initiated coverage on Vicore Pharma Holding AB with a 'Buy' rating and a $15 price target.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading